Fig. 3.

Mel-ADMSCs therapy upregulated the protein and cellular expressions of androgen receptor and vimentin by 72 h after TTIR procedure. A Protein expression of vimentin, * vs. other groups with different symbols (†, ‡, §), p < 0.0001. B Protein expression of androgen receptor (AR), * vs. other groups with different symbols (†, ‡, §), p < 0.0001. C–G Illustrating the immunohistochemical (IHC) stain for identification of AR+ cells (gray color). H Analytical result of number of AR-positively stained cells, * vs. other groups with different symbols (†, ‡, §), p < 0.0001. I–M Showing the IHC stain for identification of vimentin + cells (gray color). N Analytical result of number of vimentin-positively stained cells, * vs. other groups with different symbols (†, ‡, §), p < 0.0001. All statistical analyses were performed by one-way ANOVA, followed by Bonferroni multiple comparison post hoc test (n = 6 for each group). Symbols (*, †, ‡, §) indicate significance (at 0.05 level)